Law & Practice
SINGAPORE: IPOS Examiner Rejects Registration of Scientific Abbreviation
Published: October 16, 2024
Lin Lixia Mirandah Asia (Singapore) Pte Ltd Singapore INTA Bulletins—Asia-Pacific Subcommittee
Verifier
Renee Xavier Alpha & Omega Law Corporation Singapore
The Intellectual Property Office of Singapore (IPSO) has refused to register a scientific abbreviation as a trademark even though the applicant was the first to discover the substance.
In the matter of a trademark application by BioMedical Research Group Inc. & Anor. ([2024] SGIPOS 3), BioMedical Research Group Inc. and Macrophi Inc. sought to register the mark in Classes 3, 5, 30, 31, and 32 for “non-medicated toiletry preparations; bath preparations, not for medical purposes.” The term “IP-PA1” is an abbreviation of the words “immunopotentiator from Pantoea agglomerans 1.”
The word “immunopotentiator” is a portmanteau of the words “immune” and “potentiate,” while “Pantoea agglomerans” is a type of bacteria and “1” being the specific strain of this bacterium found in wheat and various plants. Individuals linked to one of the applicants were apparently the first to discover and name the substance IP-PA1.
An objection was raised on the basis that is an abbreviation of a lipopolysaccharide, hence devoid of distinctive character and descriptive of the goods being claimed. In response, the applicants deleted all classes but Class 3 from the application.
However, the examiner raised a further objection to Class 3 on the same grounds. This was maintained by a second examiner following a request for reconsideration. The second examiner conducted a new search subsequent to the issuance of the first office action and noted a sizeable amount of interest among researchers in the scientific community on the potential benefits and applications of IP-PA1. They would perceive the mark as a descriptive term and not as an indicator of trade origin. Unable to convince the examiner to waive the objections, the applicant requested an ex parte hearing.
The adjudicator upheld the decisions of the examiners and refused the registration of the mark for lack of distinctiveness and descriptiveness, drawing a parallel with an earlier case of Abbott Laboratories v. Société des Produits Nestlé S.A. ([2019] SGIPOS 11), where an application to register the mark H-MO for infant formula and nutritional supplements was deemed, on the evidence, descriptive and nondistinctive.
After considering the evidence, the adjudicator took the view that for the same reasons, the mark was also devoid of distinctive character, and he refused registration.
He said one could argue persuasively that the mark has since become generic based on the evidence and would therefore be unregistrable, and that the applicants were attempting to monopolize an accepted abbreviation.
Although every effort has been made to verify the accuracy of this article, readers are urged to check independently on matters of specific concern or interest. Law & Practice updates are published without comment from INTA except where it has taken an official position.
© 2024 International Trademark Association
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
To find out more please see our Cookies Policy and Privacy Policy.
These cookies are used to identify a user’s browser as the visitor goes from page to page on the Site. These are session cookies, which means that the cookie is deleted when you leave the Site. It is an integral piece of the Site software and used to let the server know which users are on the Site at any given time and make certain parts of the Site easier to use.
|
|
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
These cookies are used to collect information about how visitors use our Site. The cookies collect information in anonymous form, including the numbers of visitors to the Site, where visitors have come to the Site from, the pages they visited and how they have interacted with tools on the Site like search and embedded media players. We use the information to compile statistical reports of our users’ browsing patterns so that we can improve the Site.
|
|
Please enable Functionality Cookies first so that we can save your preferences!
These cookies are used to deliver advertising relevant to the interests of visitors to our Site. They are persistent, which means they will remain on your device after you leave the Site.
- Facebook (Ad Pixel)
- Google (Ad Pixel)
- LinkedIn (Ad Pixel)
- Quattro Anonymous
Please enable Functionality Cookies first so that we can save your preferences!